Follows people taking avacopan long term for rare blood vessel inflammation
Studies safety and effects of long-term avacopan in people with MPA or GPA.
Plain-language title generated from the registry record
Registry title: Special Drug Use-results Survey for Long-term Use（Avacopan）
Key facts
- Where
- Multiple Locations, JapanSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The survey is looking for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis who are being treated with avacopan, to study its long-term safety and effect.
- Sex
- All sexes can join.
- Disease stage
- Microscopic polyangiitis or granulomatosis with polyangiitis.
- Earlier treatment
- People must be treated with avacopan.
Read by machine on 12 November 2026.
Where in Japan
- Multiple LocationsHospital not named in the registryContact: Kazunori Abe, directorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Kissei Pharmaceutical Co., Ltd.
- Trial code
- NCT06758271
- Record updated
- 17 January 2025
- Original description
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.Read full original descriptionShow less
Special Drug Use-results Survey for Long-term Use
The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.
Inclusion: Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan.